NDC 68382-354 – Bupropion
Bupropion Hydrochloride 300 mg/1 · Tablet, Extended Release · Oral
Product NDC68382-354
Product details
- Brand name
- Bupropion
- Generic name
- Bupropion
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA201567
- Marketed since
- February 15, 2014
- Listing expires
- December 31, 2026
- Pharmacologic class
- Aminoketone
Active ingredients
- Bupropion Hydrochloride 300 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 68382-354-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-05) | Feb 15, 2014 |
| 68382-354-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-06) | Feb 15, 2014 |
| 68382-354-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-10) | Feb 15, 2014 |
| 68382-354-16 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-16) | Feb 15, 2014 |
Recalls mentioning this NDC
- D-0207-2017 Dec 28, 2016 · Class III
Failed Dissolution Specifications; 6 month time point - D-0149-2017 Nov 30, 2016 · Class III
Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.
Other Bupropion products
- 71335-0801 Bupropion Hydrochloride 200 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 63187-521 Bupropion Hydrochloride 300 mg/1 · Tablet, Extended Release · Proficient Rx LP
- 71205-565 Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Proficient Rx LP
- 65841-780 Bupropion Hydrochloride 300 mg/1 · Tablet, Extended Release · Zydus Lifesciences Limited
- 65841-836 Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Zydus Lifesciences Limited
- 68382-353 Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Zydus Pharmaceuticals USA Inc.
- 51655-357 Bupropion Hydrochloride 150 mg/1 · Tablet, Film Coated, Extended Release · Northwind Health Company, LLC